Chronic Kidney Disease and the Pathophysiology of Valvular Heart Disease

Area of Science:

• Nephrology
• Cardiology
• Biomedical Engineering

Background:

• Valvular heart calcification and disease (VHD) are prevalent in chronic kidney disease (CKD) patients, especially those on hemodialysis, correlating with poor prognosis.
• CKD accelerates VHD progression and bioprosthetic valve deterioration, driven by bone metabolism dysregulation and left ventricular remodeling, increasing heart failure and mortality risks.

Purpose of the Study:

• To highlight the increased prevalence and severity of valvular heart disease in CKD patients.
• To emphasize the unique pathophysiological mechanisms and clinical implications of VHD in CKD.
• To recommend updated diagnostic and therapeutic strategies for VHD in advanced CKD.

Main Methods:

• Review of existing literature on valvular heart disease in chronic kidney disease.
• Analysis of pathophysiological links between CKD, bone metabolism, and cardiovascular calcification.
• Evaluation of current diagnostic guidelines and treatment options for VHD in CKD patients.

Main Results:

• CKD patients exhibit a procalcifying phenotype due to bone metabolism dysregulation, exacerbating VHD.
• Left ventricular remodeling in CKD contributes to heart failure and mortality in VHD patients.
• No current medical treatments effectively prevent or reduce valvular calcification in CKD.

Conclusions:

• Advanced CKD patients require regular echocardiography for VHD screening.
• More frequent VHD monitoring is necessary for CKD patients compared to general guidelines.
• Transcatheter valve replacement may be a preferred option for severe aortic stenosis in CKD patients.